UW–Madison researchers identify therapeutic target for dangerous fungal infections
A multidisciplinary team of researchers at UW–Madison has identified a promising new therapeutic candidate against Candida auris, an emerging fungal pathogen able to resist multiple antifungal drugs and spread rapidly through hospitals and care facilities.
Charles “Chuck” Mistretta, PhD, a pioneering researcher who transformed the field of medical imaging, passed away on June 9, 2026. The University of Wisconsin–Madison professor emeritus of medical physics, radiology, and biomedical engineering had a profound impact on both the field and his students and collaborators. Mistretta was a beloved teacher and brilliant researcher. He entered medical imaging without conventional training in the field and transformed it through discoveries that led to new instruments, central to diagnosis and treatment of vascular disease today. Mistretta was best known for developing digital subtraction angiography, a medical imaging technique that allowed physicians to visualize blood vessels in real time with greater clarity, which made the development of minimally invasive, image-guided interventions possible. Mistretta also helped advance magnetic resonance angiography, developing a technology that improved imaging of contrast dye as it passes through the vascular system, giving physicians a more reliable view of blood flow over time.
